As in our results, they demonstrated a significant trend toward choroidal thinning from the third month of therapy, which was sustained for 1 year.
← all excerpts
Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.
1
—
—